Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes *Advertisement*
Phillip Home Send to Friends Free Subscription Give Comments 中文版
14 Aug, 2017 (Monday)

            
SHANDONG XINHUA(719)
Analysis:
In the first half ended 30 June 2017, Shandong Xinhua Pharmaceutical Company (719) recorded operating revenue of RMB2.403 billion, representing an increase of 20.25%. The Group recorded rapid growth in various business sectors. Net profit attributable to shareholders increased 132.8% to RMB106 million. Gross profit margin improved by 7.21 percentage points to 27.46%. The Group`s modern medicine international cooperation centre will commence operation this year. The centre will bring about more international projects to the Group. (I do not hold the above stock)
Strategy:
Buy-in Price: $7.20, Target Price: $7.95, Cut Loss Price: $6.85

CHINASOFT INT`L(354)
Analysis:
Chinasoft International has become Huawei cloud's first "work-in-unity" partner which symbolizes another milestone of mutual cooperation. It will be a parallel software development company that is equivalent to Huawei and share the common task of packaging and selling Huawei cloud services. Furthermore, it will focus more on developing SMAC (social, mobile, analytics and cloud) and other services that have higher margin. We believe that the Company will continuously benefit from the strong growth of domestic informatization, IT localization, offshore IT outsourcing market, cloud computing and other emerging businesses. Its contribution from major clients will rise steadily.
Strategy:
Buy-in Price: $4.12, Target Price: $5.00, Cut Loss Price: $3.90


Hongkong & Shanghai Hotels (45.HK) - The CapEx Will Provide Good Return on Investment

Investment Summary

- Renovation of The Peninsula Beijing will provide substantial growth in RevPAR and is expected to more than offset the effect on revenue caused by the decrease in number of rooms

- New hotel construction projects are on good track

Business Overview

1H2017 result was better than our expectation: Hongkong & Shanghai Hotels had a tiny drop in revenue of about 0.4% to HK$2,596Mn in 1H2017. However, EBITDA increased 7% to HK$561Mn, primarily because of the general recovery in the hotel segment. Profit attributable to the shareholders increased 162% in 1H2017 to HK$519Mn. The reason for the rapid increase in profit attributable to the shareholders is throughout 1H2017, the increase in fair value of investment properties increased 565% to HK$359Mn, which contributes to a substantial proportion of the increase in the profit. Out of the HK$359 revaluation gain, a large majority of the increase in fair value was contributed by The Repulse Bay Complex. Excluding the fair value changes of investment properties and other non-recurring items attributable to shareholders, the underlying profit increased 19%, representing a HK$0.12 underlying earnings per share.

The Peninsula Beijing renovation are being completed in phases: In FY2015, the company started the renovation of The Peninsula Beijing. The first phase was completed in September 2016 and the second phase is expected to be completed in August 2017. Originally, there were 525 rooms in The Peninsula Beijing but after the renovation, the rooms has been combined and the number of room has decreased to 230. However, the size of the room has increased and is the largest in Beijing, allowing the hotel to become the market leader in terms of room rates in 1H2017. The dining outlets have been renovated and the shopping arcade has successfully retained most of the tenants. In particular, the company has implemented a strategy to focus on diplomatic and group booking so that The Peninsula Beijing could take advantage of the increasing number of conferences taking place in Beijing.

Benefitting from the renovation of The Peninsula Beijing and the expansion of the rooms, The Peninsula Beijing had a sizable growth in 1H2017, with RevPAR increasing by almost 300%. Therefore, when all the rooms become available, the company is expected to experience even higher room rate growth because the room rates in 1H2017 was temporarily suppressed by the partial closure and disruption in the hotel due to the renovation of the second phases of rooms.

New hotel construction projects are on track: The Peninsula London project is currently on track and the last office tenant moved out in April 2017. The hotel will have 189 rooms and 24-28 luxury residential apartments, which we expect the profit from the luxury apartments to cover the majority of the construction cost of the project, currently budgeting at around GBP600Mn. Demolition of the current site has begun and the expected completion date of The Peninsula London is FY2021.

For The Peninsula Istanbul, the company has started the demolition for the site. The Peninsula Istanbul will be a 180-room hotel by the waterfront and is part of the larger Galataport project consisting of museums, galleries, restaurants and parks. Moreover, the recent improvement in relationship between Russia and Turkey will attract more Russian tourists to travel to Istanbul, thus allowing The Peninsula Istanbul to expand its target customer group not only to Gulf nations but also to Russia. The expected completion date for the hotel is FY2019.

Investment property business continues to be stable: The Repulse Bay Complex remained to be the largest revenue contributor of the investment property business in 1H2017, contributing HK$310Mn or 66.5% of the total revenue of the investment property segment. The Peak Tower was the second largest revenue contributor and was fully leased throughout the reporting period. Additional revenue was received from Sky Terrace 428, which at the same time had a combination ticket arrangement with The Peak Tram. The company was granted a further 10-year operating rights for The Peak Tram subject to improvement project being satisfactory to the government. We view this as an encouraging opportunity as The Peak Tower, along with The Peak Tram and Sky Terrace 428, will provide synergy, thus generating stable recurring revenue to the company.

1-5 Grosvenor Place, the site for The Peninsula London, has been vacated in the reporting period. The revenue contributed by this investment property was HK$14Mn throughout the reporting period. Since demolition has started, the property will no longer be classified as investment property and will not provide any rental revenue. Therefore, we expect the revenue from the investment property segment to remain at current level.

Investment Thesis, Valuation and Risk

Our valuation model suggests a target price of HK$12.50: Hongkong & Shanghai Hotels has several new hotel construction projects and they are on track. Further to that, The Peninsula Istanbul will be completed in FY2019 and will definitely be benefit from the recovery in the relationship between Russia and Turkey, thereby allowing the hotel to expand its customer group to Russian visitors apart from the Arabian visitors. Moreover, The Peninsula Beijing has almost completed its renovation and the RevPAR has been better than our original expectation. Therefore, we have altered our expectation on the financial performance and raised the target price to HK$12.50, corresponding to a P/E and P/B of 19.52x and 0.55x, with a `Neutral` rating assigned. (Closing price as at 10 Aug 2017)

Financials

Click Here for PDF format...




Recommendation on 14-8-2017
RecommendationNeutral
Price on Recommendation Date$ 13.180
Suggested purchase priceN/A
Target Price$ 12.500
Writer Info
John Wong
(Research Analyst)
Tel: +852 2277 6527
Email:
johnycwong@phillip.com.hk

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Phillip Research - Hong Kong 輝立研究部 – 香港及中國
Company Stock Code Last Update Suggestion Target Price Price on Recom
Information Techology Research Department N/A+852 2277 6527research@phillip.com.hk
Goldpac Group331527/03/2017Buy32.4
O-Net Technologies87727/09/2016No Rating4.02
Transportation and Automobiles Zhang Jing (86) 2151699200-103zhangjing@phillip.com.cn
GWM233310/08/2017Accumulate11.510.34
Brilliance China111403/08/2017Accumulate2319.3
Insurance Research Department (86) 21 51699400-110research@phillip.com.cn
Media & Publishing Research Department (+ 86 21 51699400-107)research@phillip.com.cn
Wisdom Sports Group166111/07/2016Buy3.32.18
NetDragon77716/06/2016Buy28.422.9
Pharmaceutical Fan Guohe  (+ 86 21 51699400-110)fanguohe@phillip.com.cn
Hengrui Medicine60027602/08/2017Accumulate 56.551.2
Kanion Pharmaceutical60055725/07/2017BUY20.216.17
Industrial Goods Ocean Pan +852 2277 6515oceanpan@phillip.com.hk
DONGJIANG ENV89511/08/2017Buy13.810.64
DONGJIANG ENV89515/05/2017Buy14.812.16
Health & Personal Care Fan Guohe  (+ 86 21 51699400-110)fanguohe@phillip.com.cn
HEC Pharm155802/06/2017Buy22.2417.08
Luye Pharma218622/03/2017Buy6.34.95
New Energy Wang Yannan 86 21 51699400-107wangyannan@phillip.com.cn
HN RENEWABLES95827/02/2017Buy3.52.72
CONCORD NE18224/10/2016Buy0.60.39
Food, Beverage and Retail Research Department (86) 21 51699400-110research@phillip.com.cn
L`OCCITANE97322/05/2017Accumulate1715.3
L`OCCITANE97319/05/2017Accumulate1715.3
Textiles & Clothing Ocean Pan +852 2277 6515oceanpan@phillip.com.hk
JNBY330613/04/2017Accumulate6.65.95
CECEP COSTIN New Materials Group222818/10/2013Buy5.64.23
Telecommunications Fan Guohe + (86) 21 51699400-110fanguohe@phillip.com.cn
Chinasoft International35409/08/2017Buy5.884.39
Chinasoft International Ltd35410/04/2017Buy5.84.61
Mainland Property John Wong +852 2277 6527johnycwong@phillip.com.hk
Longfor Properties96021/07/2017Accumulate20.3519
China Overseas Land & Inv68822/06/2017Accumulate25.122.85
Basic Materials Ocean Pan +852 2277 6515oceanpan@phillip.com.hk
Yip's Chemical40815/06/2017No Rating3.29
ND Paper268905/04/2017Accumulate9.58.35
Utilities Research Department +852 2277 6527research@phillip.com.hk
ZFET Co.,Ltd.00247904/08/2017Buy15.611.15
YUNNAN WATER683927/07/2017Buy4.63.47
Properties John Wong +852 2277 6527johnycwong@phillip.com.hk
Fortune REIT77808/08/2017Neutral9.59.69
Fortune REIT77807/08/2017Neutral9.59.69
Software & Service Research Department (86) 21 51699400-110research@phillip.com.cn
IGG800221/11/2014Accumulate3.953.44
HC INTERNATIONAL228006/11/2014Buy14.928.8
Hotels and Entertainment John Wong (+ 852 2277 6527)johnycwong@phillip.com.hk
Hongkong & Shanghai Hotels4514/08/2017Neutral12.500.000
Jinjiang Hotels200608/07/2016Accumulate2.982.49

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

版權所有, 翻印必究。

Copyright(C) 2017 Phillip Securities (HK) Ltd. All Rights Reserved.